CR
Clinician's Roundtable
ReachMD
Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
- 20 episodes
- weekly
- Avg 8 min
- English
- CRAugust 31 · 14 min
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Host: Shelina Ramnarine, PhD Guest: David A. Johnson, MD, FACG, FACP Noninvasive colorectal cancer screening is only effective when abnormal results lead to timely, high-quality colonoscopy, but recent data shows significant gaps in follow-up. Join Dr. Shelina Ramnarine and Dr. David Johnson, Chief of Gastroenterology at Eastern Virginia Medical School at Old Dominion University, as they explore how primary acre clinicians can set expectations with patients, address barriers to follow-up, and strengthen workflows and care coordination to close the loop.
- CRAugust 31 · 13 min
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Mallik Greene, PhD Guest: Jordan Karlitz, MD A study published in the Journal of the National Comprehensive Cancer Network examined follow-up colonoscopy rates after positive stool-based colorectal cancer screening tests, finding notably higher and faster completion rates with multi-target stool DNA testing compared to fecal immunochemical testing. These findings highlight the critical role of patient navigation in closing follow-up gaps and reducing disparities across racial and ethnic groups. Joining Dr. Peter Buch to discuss their research and its implications for everyday practice are Dr. Mallik Greene and Dr. Jordan Karlitz. Dr. Greene is a health economics and outcome research expert at Abbott Cancer Diagnostics, and Dr. Karlitz is a volunteer gastroenterology professor at the University of Colorado School of Medicine and a Senior Medical Officer at Abbott Cancer Diagnostics. Read the JNCCN study: Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity
- CRAugust 17 · 14 min
Improving Long-Term Adherence to CRC Screening Recommendations
Host: Brian P. McDonough, MD, FAAFP Guest: David A. Lieberman, MD Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abnormal results. But real-world data shows that many patients fall off track over time. Learn more about how we can improve adherence, reduce disparities, and strengthen continuity across the screening pathway as Dr. Brian McDonough sits down with Dr. David Lieberman, Professor Emeritus in the Department of Medicine and former Chief of the Division of Gastroenterology and Hepatology at Oregon Health & Science University in Portland.
- CRAugust 13 · 14 min
Improving IV Medication Accuracy with Smart Pump Safety Procedures
Host: Shelina Ramnarine, PhD Guest: Samuel Ubanyionwu, PharmD, EMBA Accurate IV medication delivery depends on more than proper pump programming alone. It requires a comprehensive understanding of smart pump drug libraries, dose error reduction software (DERS), infusion mechanics, and system-level safety procedures. To explore how these elements work together to support IV medication accuracy, patient safety, and clinical decision-making, Dr. Shelina Ramnarine speaks with Dr. Samuel Ubanyionwu, Medication Management Informaticist in Pharmacy Services and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine.
- CRJuly 30 · 3 min
Helping Patients with IgAN Navigate Treatment Decisions
Guest: Sayna Norouzi, MD Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication techniques for explaining prognosis, setting expectations around therapy, and partnering with patients to support informed treatment decisions and long-term kidney health. Dr. Norouzi is an Associate Professor of Medicine and Clinical Nephrologist at Loma Linda University Medical Center in California. She's also the Founder and Director of the Glomerular Diseases Clinic at Loma Linda and Director of the GlomCon Glomerular Diseases Fellowship Program.
- CRJuly 23 · 2 min
Seeking Expert Opinions in IgAN Care
Guest: Anjay Rastogi, MD, PhD Managing IgA nephropathy (IgAN) is becoming increasingly complex. In this episode, Dr. Anjay Rastogi explains why an expert opinion—not simply a second opinion—can help clinicians confirm diagnoses, optimize treatment decisions, and connect appropriate patients with specialized care and emerging therapeutic opportunities. Dr. Rastogi is a Professor of Medicine and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA. He's also the Director of the UCLA CORE Kidney Health Program.
- CRJuly 23 · 2 min
The Pathologist’s Role in IgAN Management
Guest: Anjay Rastogi, MD, PhD Closer collaboration between nephrologists and pathologists is essential for optimizing the diagnosis and management of IgA nephropathy (IgAN). Hear from Dr. Anjay Rastogi as he highlights how pathology insights, clinical context, and ongoing communication can improve interpretation of kidney biopsy findings and support more informed treatment decisions. He's a Professor of Medicine and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, as well as the Director of the UCLA CORE Kidney Health Program.
- CRJuly 20 · 11 min
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Host: Alexandria May, PharmD, BCPS Guest: David E. Griffith, MD Even as our understanding of nontuberculous mycobacterial (NTM) lung disease advances, major gaps remain, from defining meaningful treatment success to overcoming innate drug resistance. In this conversation with Dr. Alexandria May, Dr. David Griffith shares his perspective on how recent evidence is shaping treatment decisions for these patients and explains why significant unmet needs persist. Dr. Griffith is a Professor of Medicine in the Division of Mycobacterial and Respiratory Infections within the Department of Medicine at National Jewish Health in Denver.
- CRJuly 20 · 14 min
Early Recognition and Diagnostic Confidence in NTM Lung Disease
Host: Brian P. McDonough, MD, FAAFP Guest: Doreen Addrizzo-Harris, MD The biggest challenge in diagnosing nontuberculous mycobacterial (NTM) lung disease isn't confirmation; it's thinking to look for NTM in the first place. In this conversation with Dr. Brian McDonough, Dr. Doreen Addrizzo-Harris examines the subtle clinical and radiographic features that can help identify NTM earlier, discusses best practices for obtaining diagnostic cultures, and reviews how guideline-based criteria can help distinguish active disease from colonization. Dr. Addrizzo-Harris is the Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care, and Sleep Medicine at NYU Grossman School of Medicine, as well as the Director of the Bronchiectasis and NTM Program at NYU Langone Health.
- CRJuly 14 · 14 min
Clinical Features and Outcomes of IOFB Removal
What do large registry data reveal about outcomes after intraocular foreign body removal, and how should those findings shape surgical planning and patient counseling? In this episode of New Retina Radio Journal Club with VBS, Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and Rehan Hussain, MD, on a 2025 IRIS Registry analysis of nearly 4,800 eyes. The group reviews the delayed timeline of visual recovery, the risk of late complications, and practical guidance on staging surgical intervention and setting realistic expectations in complex trauma cases.
- CRJuly 6 · 4 min
Socioeconomic Determinants and Outcomes in Proliferative Sickle Retinopathy
Host: Maria Berrocal Guest: Audina Berrocal, MD Does socioeconomic status influence outcomes in proliferative sickle retinopathy? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Audina "Nina" Berrocal, MD, of Bascom Palmer Eye Institute, who published a retrospective review of more than 100 patients with proliferative sickle retinopathy. They explore whether the integrated care model at Bascom Palmer may account for results that don't translate to other parts of the country. The conversation also touches on newborn screening programs in Florida and the importance of sickle cell centers in high-incidence communities.
- CRJuly 1 · 2 min
Bridging the Gap Between Evolving Science and Patient Understanding
Guest: Jason Goldman, MD Scientific uncertainty is inevitable, but how we communicate it matters. Dr. Jason Goldman, President of the American College of Physicians and liaison to the CDC Advisory Committee on Immunization Practices, shares strategies for discussing the unknown with patients transparently and effectively.
- CRJune 23 · 4 min
Rising Colorectal Cancer in Young Adults: Implications for Screening
Guest: Christopher Cann, MD Colorectal cancer is increasingly affecting younger adults, highlighting important gaps in current screening practices. Given this alarming trend, Dr. Christopher Cann discusses how rising incidence in patients under 50 challenges traditional screening thresholds and underscores the need for earlier risk assessment. He emphasizes the importance of family history, identifying high-risk individuals who may benefit from earlier screening, and maintaining a low threshold to evaluate persistent symptoms. Dr. Cann is an Assistant Professor in the Department of Hematology Oncology at Fox Chase Cancer Center in Philadelphia, where he's also the Director of the Young Adult Cancer Program.
- CRJune 23 · 14 min
Navigating NTM Lung Disease: A Patient-Centered Approach
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kenneth Olivier, MD, MPH Guest: Shelby MacRae, MD In patients with nontuberculous mycobacterial (NTM) lung disease, treatment decisions rarely follow a one-size-fits-all approach. In this expert-led discussion, Dr. Kenneth Olivier and Dr. Shelby MacRae join Dr. Charles Turck to explore how disease characteristics, patient priorities, and evolving clinical factors can inform individualized treatment strategies across the NTM care continuum. Dr. Olivier is the Michael E. Hatcher Distinguished Professor of Medicine, Microbiology, and Immunology at the University of North Carolina School of Medicine, where he also serves as Research Director of the Bronchiectasis and NTM Care and Research Center. Dr. MacRae is an Assistant Professor of Pulmonary and Critical Care Medicine and Director of the Environmental Lung Disease, Bronchiectasis, and NTM Program at Louisiana State University Health Sciences Center in New Orleans.
- CRJune 23 · 2 min
Patient Navigators’ Role in Improving Colorectal Cancer Screening
Guest: Christopher Cann, MD Patient navigators play an increasingly vital role in improving colorectal cancer screening rates and closing gaps in preventive care. Beyond care coordination, they serve as key educators by identifying eligible patients, addressing barriers, and facilitating referrals for screening colonoscopy and other modalities. Learn more about how integrating patient navigation can enhance adherence and ultimately improve patient outcomes with Dr. Christopher Cann, Assistant Professor in the Department of Hematology Oncology and Director of the Young Adult Cancer Program at Fox Chase Cancer Center in Philadelphia.
- CRMay 22 · 10 min
Shared Decision-Making in Colorectal Cancer Screening
Host: Gates B. Colbert, MD Guest: Sarina Schrager, MD Guest: Lashika Yogendran, MD Shared decision-making plays a critical role in improving colorectal cancer screening uptake by helping patients navigate emotional, logistical, and personal barriers to care. Joining Dr. Gates Colbert to discuss how individualized, patient-centered conversations can support screening decisions and improve completion rates are Dr. Sarina Schrager and Dr. Lashika Yogendran. Dr. Schrager is a family medicine physician at the University of Wisconsin School of Medicine and Public Health, where she focuses on preventative care, women's care, and patient-centered decision-making. Dr. Yogendran is a family medicine physician at UW Health and an Assistant Professor at the University of Wisconsin School of Medicine and Public Health, Department of Family Medicine and Community Health.
- CRMay 13 · 13 min
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Despite strong recommendations for colorectal cancer screening, many eligible patients are still unscreened because of access and convenience issues. Emerging blood-based screening tests may help expand participation, but important questions remain about their ability to detect advanced precursor lesions and how they compare with established screening approaches. Joining Dr. Peter Buch to discuss the evolving role of blood-based colorectal cancer screening and what clinicians should know about these new testing strategies is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine at the NYU Grossman School of Medicine and the Director of Outcomes Research in Gastroenterology.
- CRMay 11 · 2 min
Improving CRC Screening Workflows: A PCP's Recommendations
Guest: Natalia Usoltseva MD, FACP, MHA Colorectal cancer (CRC) screening is most effective when it fits seamlessly into busy primary care workflows while still keeping patients engaged in the process. Join Dr. Natalia Usoltseva as she discusses practical ways to improve screening, from simplifying shared decision-making conversations and automating follow-up processes to ensuring patients receive the individualized support they need to stay on track with preventive care. Dr. Usoltseva is a primary care provider at University of Washington Medicine.
- CRMay 11 · 3 min
Improving CRC Screening Conversations in Primary Care
Guest: Natalia Usoltseva MD, FACP, MHA Shared decision-making can be difficult to incorporate into already time-constrained primary care visits, especially when discussing colorectal cancer screening (CRC) options with patients. Join Dr. Natalia Usoltseva, a primary care provider at University of Washington Medicine, to hear how her practice implemented standardized decision-making tools to create more efficient, patient-centered conversations and improve colorectal cancer screening adherence.